Are there any mid-year revisions to the ASC fee schedule?
Yes. Because drug reimbursement updates on a quarterly basis and some drugs are separately reimbursed to the ASC, quarterly updates are made to the ASC fee schedule. For example, HCPCS code J2778 (Lucentis), when utilized in the ASC, reimbursed $406.18 for 0.1 mg from January through March 2008. The ASC update effective April 1, 2008 changed the reimbursement to $405.18 for 0.1 mg. Watch for quarterly updates on the CMS website. Q: Are there additional deadlines associated with the NPI number implementation? A: No. The requirement that you use only National Provider Identification numbers on your claims was effective on May 23, 2008. CMS reports a relatively smooth transition, although some carriers did report difficulties. Some physician practices continue to have NPI issues and have been instructed to work directly with the customer service representatives at their local carrier. Q: Did the NPI deadline affect claims for post-cataract eyeglasses? A: Yes. On April 1, 2008, CMS publish
